Dr. Michael Chambers Elected Chairman of ProUroCare Board of Directors
NIH Awards $1.1M Grant to Mitchell Cancer Institute
The Laura Crandall Brown Ovarian Cancer Foundation
Gene Capture, recently announced that Dr. Michael Chambers of Swift Biotech, has been named to its Board of Directors.
The Biotechnology Association of Alabama recently selected Dr. Michael Chambers of Swift Biotechnology, to membership in its Board of Directors.
InQBio Sciences, based in Huntsville, Alabama, recently announced that Dr. Michael Chambers of Swift Biotech, has been selected to its Board of Directors.
Swift Biotechnology’s development efforts are featured in Alabama Technology magazine
ProUroCare (PUMD:NASDAQ), based in Minneapolis, Minnesota, announced that Dr. Michael Chambers has been named to its Board of Directors.
Swift Biotechnology selected as one of three winners of the Governor’s Annual Launchpad Business Plan Competition taking home $50,000 prize!
Swift Biotechnology LLC
Mitchell Cancer Institute Complex
1660 Springhill Avenue
Mobile, AL 36604
Copyright © 2010 - 2014 Swift Biotechnology. All Rights Reserved. | Website developed by Webjed
Swift Biotechnology is not owned by, related to or directly affiliated with the University of South Alabama or the Mitchell Cancer Institute.
Site developed by Webjed